ArticleEuropean journal of pediatrics2026
Clinical delineation and genotype-phenotype correlation of 84 pediatric patients with Cornelia de Lange syndrome: insights from a single-center Chinese study.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Cornelia de Lange syndrome (CdLS) is a rare genetic disorder, which has clinical and genetic heterogeneity. This study investigated the clinical and genetic characteristics of a large cohort of CdLS in China and elucidated genotype-phenotype correlations. The clinical manifestations, laboratory tests, and genetic testing of pediatric participants from January 2011 to December 2025 were retrospectively analyzed. We compared clinical phenotypes of patients with NIPBL variants versus those with variants in other causative genes, as well as among patients with different types of NIPBL variants. A total of 84 Chinese patients diagnosed with CdLS were included in this cohort. Growth curve analysis delineated distinct sex-specific patterns. Male patients experience severe growth faltering during puberty, suggesting an underlying deficit in sex hormone drive. This is further corroborated by the significant growth acceleration achieved with hormone replacement therapy in a male patient diagnosed with hypogonadotropic hypogonadism. NIPBL variants were the predominant cause, accounting for 66.7% of cases, and correlated with the most severe phenotypic spectrum. Notably, this subgroup exhibited significantly more severe growth retardation and a higher frequency of classic facial features (p < 0.001). Furthermore, severe upper limb deformities, such as oligodactyly, were identified exclusively in the NIPBL subgroup.Conclusion: This study characterized a Chinese CdLS cohort, establishing its first growth curves and observing a positive growth response to hormone therapy. Our findings confirm the link between NIPBL variants and the most severe phenotype, thereby underscoring the necessity of a genotype-stratified approach for clinical management and counseling.
Indexed as
Identifiers
42207311What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.